Sensitization to Api m 1, Api m 2, and Api m 4: association with safety of bee venom immunotherapy

Ann Allergy Asthma Immunol. 2015 Apr;114(4):350-2. doi: 10.1016/j.anai.2015.01.010. Epub 2015 Feb 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Allergens / immunology*
  • Animals
  • Bee Venoms / therapeutic use*
  • Bees / immunology
  • Biomarkers / metabolism
  • Desensitization, Immunologic / methods*
  • Disease Progression
  • Female
  • Humans
  • Hyaluronoglucosaminidase / immunology*
  • Hypersensitivity / immunology
  • Hypersensitivity / therapy*
  • Immunization
  • Immunoglobulin E / blood
  • Insect Proteins / immunology*
  • Male
  • Melitten / immunology*
  • Middle Aged
  • Phospholipases A / immunology*
  • Young Adult

Substances

  • Allergens
  • Bee Venoms
  • Biomarkers
  • Insect Proteins
  • Melitten
  • Immunoglobulin E
  • Phospholipases A
  • Api m 1 allergen, Apis mellifera
  • Api m 2 allergen, Apis mellifera
  • Hyaluronoglucosaminidase